1-20 of 67
Authors: Martin Glas
Save search
Sort by
Journal Article

NIMG-10. THE ROLE OF FIBROBLAST ACTIVATION PROTEIN IN GLIOBLASTOMA AND GLIOSARCOMA – A COMPARISON OF TISSUE, 68GA-FAPI-46 POSITRON EMISSION TOMOGRAPHY AND SURVIVAL DATA

PDF
Christoph Oster and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii196–viii197, https://doi.org/10.1093/neuonc/noae165.0776
Published: 11 November 2024
Journal Article

CTIM-08. FIRST IN HUMAN STUDY OF THE MRNA-BASED CANCER VACCINE CVGBM IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA (GBM): FIRST RESULTS FROM THE DOSE ESCALATION PHASE

PDF
Ghazaleh Tabatabai and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii86, https://doi.org/10.1093/neuonc/noae165.0341
Published: 11 November 2024
Journal Article

CTNI-85. FINAL RESULTS FROM N2M2/NOA-20

PDF
Wolfgang Wick and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii117, https://doi.org/10.1093/neuonc/noae165.0451
Published: 11 November 2024
Journal Article

CTNI-13. 18-FET-PET ENHANCED DIAGNOSIS OF PSEUDOPROGRESSION IN GLIOBLASTOMA IS AN INDEPENDENT PROGNOSTIC FACTOR FOR OVERALL SURVIVAL

PDF
Teresa Schmidt and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii97, https://doi.org/10.1093/neuonc/noae165.0380
Published: 11 November 2024
Journal Article

CTNI-04. DECODING GLIOBLASTOMA SURVIVAL: UNRAVELING THE PROGNOSTIC POTENTIAL OF OLFACTORY FUNCTION IN A PROSPECTIVE OBSERVATIONAL STUDY

PDF
Christoph Oster and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii95, https://doi.org/10.1093/neuonc/noae165.0373
Published: 11 November 2024
Journal Article

CTNI-67. AI BASED PREDICTION OF CLINICAL TTFIELDS RESPONSE IN GLIOBLASTOMA PATIENTS (RETROSPECTIVE ANALYSIS)

PDF
Sied Kebir and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii112, https://doi.org/10.1093/neuonc/noae165.0434
Published: 11 November 2024
Journal Article

Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide Get access

PDF
Thomas Zeyen and others
Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 557–566, https://doi.org/10.1093/neuonc/noae205
Published: 01 October 2024
Journal Article

DDDR-22. PREDICTING AND TARGETING CLONALLY EXPANDING, TMZ-RESISTANT TUMOR CELLS IN GLIOBLASTOMA

PDF
Vivien Ullrich and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v110, https://doi.org/10.1093/neuonc/noad179.0416
Published: 10 November 2023
Journal Article

NIMG-82. FET PET SENSITIVITY IN PRIMARY BRAIN TUMORS ACCORDING TO CNS WHO 2021: VALUE AND PITFALLS IN PRESURGICAL IMPLEMENTATION

PDF
Christoph Oster and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v204–v205, https://doi.org/10.1093/neuonc/noad179.0777
Published: 10 November 2023
Journal Article

CTNI-62. INTERIM DATA ON DUAL INHIBITION OF POST-RADIOGENIC ANGIO-VASCULOGENESIS BY OLAPTESED PEGOL (NOX-A12) AND BEVACIZUMAB IN GLIOBLASTOMA FROM THE FIRST EXPANSION ARM OF THE PHASE 1/2 GLORIA TRIAL

PDF
Frank Giordano and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v90–v91, https://doi.org/10.1093/neuonc/noad179.0344
Published: 10 November 2023
Journal Article

CTNI-66. DECODING GLIOBLASTOMA SURVIVAL: UNRAVELING THE PROGNOSTIC POTENTIAL OF OLFACTORY FUNCTION IN A PROSPECTIVE OBSERVATIONAL STUDY

PDF
Christoph Oster and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v92, https://doi.org/10.1093/neuonc/noad179.0348
Published: 10 November 2023
Journal Article

NIMG-34. TEMPORAL MUSCLE THICKNESS AS A PROGNOSTIC MARKER IN A REAL-LIFE COHORT OF NEWLY DIAGNOSED MGMT PROMOTER METHYLATED GLIOBLASTOMA PATIENTS: A MULTICENTRIC IMAGING ANALYSIS

PDF
Lazaros Lazaridis and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v192–v193, https://doi.org/10.1093/neuonc/noad179.0730
Published: 10 November 2023
Journal Article

CTIM-12. IMMUNOGENICITY OF AN ADDITIONAL DOSE OF COVID-19 VACCINE IN FULLY VACCINATED PATIENTS WITH GLIOMA TO EVALUATE NEW NATIONAL VACCINATION GUIDELINES - A PROSPECTIVE COHORT STUDY

PDF
Teresa Schmidt and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v63–v64, https://doi.org/10.1093/neuonc/noad179.0252
Published: 10 November 2023
Journal Article

INNV-08. LONG-TERM GLOBAL POST-MARKETING SAFETY SURVEILLANCE DATA FROM PEDIATRIC, ADULT AND ELDERLY PATIENTS WITH CENTRAL NERVOUS SYSTEM MALIGNANCIES TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) THERAPY

PDF
Maciej Mrugala and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v157–v158, https://doi.org/10.1093/neuonc/noad179.0598
Published: 10 November 2023
Journal Article

CTNI-65. INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL

PDF
Sied Kebir and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v91–v92, https://doi.org/10.1093/neuonc/noad179.0347
Published: 10 November 2023
Journal Article

QOL-15. THE PIVOTAL TRIDENT STUDY OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)

PDF
Wenyin Shi and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v251–v252, https://doi.org/10.1093/neuonc/noad179.0967
Published: 10 November 2023
Journal Article

INNV-17. TREATMENT DECISION AND QUALITY OF LIFE OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA RECEIVING TUMOR TREATING FIELDS (TTFIELDS) THERAPY IN ROUTINE CLINICAL CARE: RESULTS FROM THE TIGER STUDY

PDF
Oliver Bähr and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v160, https://doi.org/10.1093/neuonc/noad179.0606
Published: 10 November 2023
Journal Article

LONG-TERM POST-MARKETING SURVEILLANCE DATA FROM ELDERLY PATIENTS WITH CENTRAL NERVOUS SYSTEM MALIGNANCIES TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) THERAPY

PDF
Maciej M Mrugala and others
Neuro-Oncology, Volume 25, Issue Supplement_3, October 2023, Page iii2, https://doi.org/10.1093/neuonc/noad147.007
Published: 16 September 2023
Journal Article

Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression

PDF
Miriam Ratliff and others
Neuro-Oncology, Volume 25, Issue 12, December 2023, Pages 2150–2162, https://doi.org/10.1093/neuonc/noad109
Published: 19 June 2023
Journal Article

TRLS-07. GLOBAL POST-MARKETING SURVEILLANCE DATA FROM PEDIATRIC AND ADULT PATIENTS WITH CENTRAL NERVOUS SYSTEM MALIGNANCIES TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) THERAPY BETWEEN 2011–2022

PDF
Maciej M Mrugala and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i80, https://doi.org/10.1093/neuonc/noad073.310
Published: 12 June 2023